Keep the data in your own house: what the EU cookie draft teaches US healthcare
October 17, 2026
October 2026
/
Europe is moving to make good analytics cheaper and bad tracking more expensive. US healthcare should pay attention.
A Council draft of the EU's Digital Omnibus, reported on October 10, 2026, would let sites set cookies without consent for first-party audience measurement, as long as the data stays anonymous, aggregated, and unshared. It would also let a site ask again four months after a visitor declines, where the Commission had proposed six, and it drops a requirement to honor browser-level consent signals. EU ambassadors were expected to take up the mandate on October 11. Parliament still has to set its own position, so none of this is law yet, and the outcome of that vote is not yet confirmed.
Read past the procedure and the lesson is clear.
What the draft actually says
The draft carves out a set of consent-free purposes centered on first-party audience measurement, on the condition that the data never identifies a person, never leaves the site's own control, and is reported in aggregate. It eases the re-ask wait to four months, and it steps back from mandating that sites honor browser-level signals. Those last two points are real give-backs to site operators, and they will be argued over.
Where it stands
This is a Council draft, not a rule. The Council has to settle its mandate, Parliament has to adopt its own position, and the two have to reconcile. Treat the specifics as a direction of travel, not a date on the calendar. The right move is to build to the final text, not the headline.
The US parallel
For years, plaintiffs' firms in the US have sued over the opposite setup: third-party pixels on appointment pages and patient portals, sending health-related signals to ad platforms. The EU exemption describes, almost line for line, the architecture that avoids those suits. Two very different legal systems are arriving at the same answer. Keep first-party data first-party.
The architecture
- First-party analytics, collected and stored under your own control.
- Server-side collection with a strict allowlist, so health and identifying fields are stripped before anything leaves your servers.
- Aggregated reporting, built so no single visitor can be singled out.
What still needs consent, on both sides of the Atlantic
This is not a license to drop the banner and track freely. Ad pixels, cross-site tracking, and session replay still require consent under both regimes, and they are still the surfaces that draw the lawsuits. The exemption is for measuring your own site, not for feeding someone else's.
If your analytics only work when you hand visitor data to an ad platform, you do not have a measurement problem. You have a design problem, and it is a solvable one. We run a 30-day audit for health systems and digital health brands that maps exactly where the data goes after the page loads, and moves the measurement in-house without losing the numbers the marketing team needs.
Sources: PPC Land, The European Post.
Ready to start a conversation about digital transformation?
Speak with our team and discuss your digital transformation.
Learn How our Pathfinder™ process Can improve your website
Schedule a meeting with our strategy team and we’ll show you how Pathfinder™ leads to project success.
Learn more about our fractional growth offering
Connect with our team to explore how a Fractional Growth Team can accelerate your marketing, UX, and digital execution, without the delays or costs of traditional models.
Curious how your site stacks up?
We’ll show you what’s working, what’s not, and where you’re leaving opportunities on the table.
Turn AI Search Into a Competitive Advantage.
See how your site can be structured to earn visibility in generative results and convert high-intent traffic into action.
Episode details
Europe is moving to make good analytics cheaper and bad tracking more expensive. US healthcare should pay attention.
A Council draft of the EU's Digital Omnibus, reported on October 10, 2026, would let sites set cookies without consent for first-party audience measurement, as long as the data stays anonymous, aggregated, and unshared. It would also let a site ask again four months after a visitor declines, where the Commission had proposed six, and it drops a requirement to honor browser-level consent signals. EU ambassadors were expected to take up the mandate on October 11. Parliament still has to set its own position, so none of this is law yet, and the outcome of that vote is not yet confirmed.
Read past the procedure and the lesson is clear.
What the draft actually says
The draft carves out a set of consent-free purposes centered on first-party audience measurement, on the condition that the data never identifies a person, never leaves the site's own control, and is reported in aggregate. It eases the re-ask wait to four months, and it steps back from mandating that sites honor browser-level signals. Those last two points are real give-backs to site operators, and they will be argued over.
Where it stands
This is a Council draft, not a rule. The Council has to settle its mandate, Parliament has to adopt its own position, and the two have to reconcile. Treat the specifics as a direction of travel, not a date on the calendar. The right move is to build to the final text, not the headline.
The US parallel
For years, plaintiffs' firms in the US have sued over the opposite setup: third-party pixels on appointment pages and patient portals, sending health-related signals to ad platforms. The EU exemption describes, almost line for line, the architecture that avoids those suits. Two very different legal systems are arriving at the same answer. Keep first-party data first-party.
The architecture
- First-party analytics, collected and stored under your own control.
- Server-side collection with a strict allowlist, so health and identifying fields are stripped before anything leaves your servers.
- Aggregated reporting, built so no single visitor can be singled out.
What still needs consent, on both sides of the Atlantic
This is not a license to drop the banner and track freely. Ad pixels, cross-site tracking, and session replay still require consent under both regimes, and they are still the surfaces that draw the lawsuits. The exemption is for measuring your own site, not for feeding someone else's.
If your analytics only work when you hand visitor data to an ad platform, you do not have a measurement problem. You have a design problem, and it is a solvable one. We run a 30-day audit for health systems and digital health brands that maps exactly where the data goes after the page loads, and moves the measurement in-house without losing the numbers the marketing team needs.
Sources: PPC Land, The European Post.
/
Host
More ways to listen
